Latest Europe News

Apollo Minerals Limited has validated significant historical tungsten intercepts up to 5.3% WO3 in unmined areas of its Couflens Project in France, highlighting exploration potential around the Veronique Zone and advancing preparations for further drilling.

Neuren Pharmaceuticals’ partner Acadia Pharmaceuticals has broadened availability of DAYBUE STIX, a new FDA-approved powder formulation of trofinetide for Rett syndrome, in the US. Early caregiver feedback and expert consensus highlight its potential role in personalised patient care.

Aldoro Resources Ltd (ASX: ARN) has announced assay results from drill hole DD005G at its Kameelburg project in Namibia, confirming 537 metres of continuous rare earth elements, strontium, and niobium mineralisation across the entire carbonatite system including the previously untested central core.

The Savana US Small Caps Active ETF (ASX:SVNP) posted a 1.28% gain in March 2026, outperforming the S&P 600 benchmark by 1.46%, supported by USD/AUD currency appreciation despite a modest portfolio decline amid geopolitical tensions.

Orbital UAV has entered the Middle East market with a USD 1.1 million order from a UAE sovereign government for its 50HFE propulsion systems and signed a long-term distribution agreement to expand its UAV propulsion presence.

Memphasys Limited (ASX: MEM) announced an investor webinar and released an updated presentation detailing its transition from early-stage commercialisation to scaling global revenues, highlighting multi-market sales, recurring cartridge revenue, and regulatory progress.

European Resources Limited has announced promising metallurgical beneficiation outcomes from its Korsnäs rare earths project in Finland, advancing the development of an integrated processing flowsheet under the EU-funded REMHub program.

Telix Pharmaceuticals posted an 11% increase in Q1 2026 revenue to US$230 million, reaffirmed full-year guidance, and reported progress in multiple clinical trials including its lead prostate cancer therapy TLX591-Tx.

Nexsen Limited (ASX:NXN) has completed its Stage 1 ISO 13485 audit, confirming its Quality Management System (QMS) supports clinical validation and regulatory submissions for its diagnostic products, including StrepSure®. The company is progressing toward full certification and alignment with MDSAP requirements to facilitate global market access.

Yugo Metals has appointed Petar Tomašević as its permanent CEO, following his interim leadership that saw significant project milestones. His international experience and regional insight position the company for accelerated growth in Europe's strategic metals sector.

The High Court of Asturias has upheld a municipal council's procedural ruling against EMC Gold’s urban plan amendment for the Salave Gold Project, leaving the project’s technical merits untouched. EMC Gold signals ongoing stakeholder engagement and alternative development strategies ahead.

Little Green Pharma has issued a supplementary scheme booklet updating Cannatrek shareholders on the acquisition progress, including a revised timetable and the termination of a planned sale and leaseback of its WA production facility. Both companies’ boards continue to recommend the scheme, supported by an independent expert’s positive assessment.